RESUMO
Detection and identification of impurities in pharmaceuticals is an essential task for determining the possible infringement of a patent. This article reports a multivariate analysis method to distinguish between tablets of the same substance on the basis of their origin, by characterizing route/process specific impurities via diagnostic ion chromatograms, using liquid chromatography/mass spectrometry (LC/MS). The approach is based on the formulation of a novel index that quantifies the similarity between LC/MS samples, named the component detection weighted index of analogy. The index estimates similarity by fully exploiting the two-dimensional nature of the data, where the relative contribution of chromatograms relates to their quality and noise level. Results show that well-defined clusters are formed according to the origin of tablets; a series of ions are identified as characterizing each class and can be used to predict the origin of unknown tablet samples. The method presented is designed for analysis of larger data sets and can be suitable for exploratory analysis where any a priori knowledge on the data is scarce or absent, hence requiring the acquisition of chromatograms in a broad m/z range.
